{"title":"关于“地点”的脚注","authors":"Mickey C. Smith","doi":"10.3109/J058V18N01_04","DOIUrl":null,"url":null,"abstract":"ABSTRACTDuring the course of the Kefauver hearings, some testimony was given that presaged some important changes in the relationships between the pharmaceutical industry and organized pharmacy and individual pharmacists. The special nature of the drug marketplace–with the pharmacist as retailer i the channel of distribution–is discussed, along with the American Pharmaceutical Association's part in the Congressional hearings. Again, significant portions of the testimony in the various hearings are reproduced, along discussion and analysis.","PeriodicalId":16734,"journal":{"name":"Journal of Pharmaceutical Marketing & Management","volume":"66 1","pages":"91-105"},"PeriodicalIF":0.0000,"publicationDate":"2006-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"A Footnote on “Place”\",\"authors\":\"Mickey C. Smith\",\"doi\":\"10.3109/J058V18N01_04\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"ABSTRACTDuring the course of the Kefauver hearings, some testimony was given that presaged some important changes in the relationships between the pharmaceutical industry and organized pharmacy and individual pharmacists. The special nature of the drug marketplace–with the pharmacist as retailer i the channel of distribution–is discussed, along with the American Pharmaceutical Association's part in the Congressional hearings. Again, significant portions of the testimony in the various hearings are reproduced, along discussion and analysis.\",\"PeriodicalId\":16734,\"journal\":{\"name\":\"Journal of Pharmaceutical Marketing & Management\",\"volume\":\"66 1\",\"pages\":\"91-105\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2006-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Pharmaceutical Marketing & Management\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.3109/J058V18N01_04\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Pharmaceutical Marketing & Management","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3109/J058V18N01_04","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
ABSTRACTDuring the course of the Kefauver hearings, some testimony was given that presaged some important changes in the relationships between the pharmaceutical industry and organized pharmacy and individual pharmacists. The special nature of the drug marketplace–with the pharmacist as retailer i the channel of distribution–is discussed, along with the American Pharmaceutical Association's part in the Congressional hearings. Again, significant portions of the testimony in the various hearings are reproduced, along discussion and analysis.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
